Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-7896

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-7896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)
Chemical structure of esomeprazole magnesium, depicted as a complex molecular formula with magnesium ion and three water molecules associated.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph showing percent maintained over a 6-month period for Esomeprazole Magnesium Delayed-Release Capsules at doses 10 mg, 20 mg, 40 mg, and placebo. The y-axis represents percent maintained from 0 to 100, and the x-axis represents months from 0 to 6. The graph includes four lines with markers for each group, showing higher percent maintained with increasing doses of Esomeprazole Magnesium compared to placebo over time.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line chart illustrating the percentage of participants maintaining a condition over six months. The graph compares Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses with a placebo group, showing higher maintenance percentages in all Esomeprazole groups compared to placebo over time.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
Line graph showing the percent of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The y-axis represents the percent of patients symptom-free, and the x-axis shows diary days from 0 to 28. Data indicates symptom-free trends across the study period for each group.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph showing the percent of patients symptom-free over a 28-day diary period. It compares three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and Placebo. The 40 mg and 20 mg groups show higher symptom-free percentages than placebo, with data points marked by different symbols.*
FDA Label Image

Label Image (Lbl500907896)

Label Image (Lbl500907896)
Label for Esomeprazole Magnesium delayed-release capsules, 40 mg strength, supplied by A-S Medication Solutions. The label indicates a package containing 90 capsules with storage instructions to keep at 68 to 77 degrees Fahrenheit. The label includes NDC 50090-7896 and a QR code linking to dosage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.